ClariVest Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-3
| Closed | – | – | 746 |
|
|
2021
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 741 |
|
|
2020
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 759 |
|
|
2020
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 757 |
|
|
2020
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 783 |
|
|
2020
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 689 |
|
|
2019
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 652 |
|
|
2019
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 672 |
|
|
2019
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 654 |
|
|
2019
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 713 |
|
|
2018
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 701 |
|
|
2018
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 724 |
|
|
2018
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 722 |
|
|
2018
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 726 |
|
|
2017
Q4 | $0 | Sell |
3
-7
| -70% | – | ﹤0.01% | 714 |
|
|
2017
Q3 | $1K | Hold |
10
| – | – | ﹤0.01% | 584 |
|
|
2017
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 600 |
|
|
2017
Q1 | $1K | Hold |
10
| – | – | ﹤0.01% | 622 |
|
|
2016
Q4 | $1K | Hold |
10
| – | – | ﹤0.01% | 604 |
|
|
2016
Q3 | $1K | Hold |
10
| – | – | ﹤0.01% | 630 |
|
|
2016
Q2 | $1K | Buy |
10
+5
| +100% | +$500 | ﹤0.01% | 579 |
|
|
2016
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 628 |
|
|
2015
Q4 | $1K | Hold |
5
| – | – | ﹤0.01% | 573 |
|
|
2015
Q3 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 548 |
|